Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

832
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
832
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

949
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
949
Symbiosis00:58

Symbiosis

36.6K
Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
36.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Economic evaluation of AI-based oral disease screening: a systematic review.

Frontiers in medical technology·2026
Same author

Diagnostic accuracy of artificial intelligence for tuberculosis detection from cough sounds: a systematic review and meta-analysis.

Frontiers in artificial intelligence·2026
Same author

Rh(III)-Catalyzed Ring Expansion and <i>exo</i>-Olefination of Urazoles with Internal Alkynes.

Organic letters·2026
Same author

Integrated tuberculosis-multimorbidity management in India: A SWOT analysis.

The Indian journal of medical research·2026
Same author

Cultural adaptation and psychometric validation of the Health Literacy Instrument for Adults with Tuberculosis (HELIA-TB) in India.

PloS one·2026
Same author

Effectiveness and implementation of a primary healthcare intervention for multimorbidity and frailty among urban older adults in India: Protocol for the Multi-FrAME cluster randomized trial.

PloS one·2026

Related Experiment Video

Updated: Dec 22, 2025

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
07:14

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Published on: July 11, 2025

458

Malaria transmission-blocking drugs: implications and future perspectives.

Ishan Wadi1, Pargat Singh1, Mahendra Nath1

  • 1Department of Chemistry, University of Delhi, Delhi, 110007, India.

Future Medicinal Chemistry
|May 8, 2020
PubMed
Summary

New antimalarial drugs are crucial for blocking malaria transmission, especially with rising resistance. This review explores preclinical antimalarials and other compounds with transmission-blocking potential to develop next-generation therapies.

Keywords:
Plasmodium falciparumantimalarialsdrugsendectocidegametocytegametocytocidalsporontocidaltransmission blocking

More Related Videos

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
05:28

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

Published on: May 12, 2022

3.5K
Building a Better Mosquito: Identifying the Genes Enabling Malaria and Dengue Fever Resistance in A. gambiae and A. aegypti Mosquitoes
15:03

Building a Better Mosquito: Identifying the Genes Enabling Malaria and Dengue Fever Resistance in A. gambiae and A. aegypti Mosquitoes

Published on: July 4, 2007

11.2K

Related Experiment Videos

Last Updated: Dec 22, 2025

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
07:14

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Published on: July 11, 2025

458
Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
05:28

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

Published on: May 12, 2022

3.5K
Building a Better Mosquito: Identifying the Genes Enabling Malaria and Dengue Fever Resistance in A. gambiae and A. aegypti Mosquitoes
15:03

Building a Better Mosquito: Identifying the Genes Enabling Malaria and Dengue Fever Resistance in A. gambiae and A. aegypti Mosquitoes

Published on: July 4, 2007

11.2K

Area of Science:

  • Malariology
  • Medicinal Chemistry
  • Parasitology

Background:

  • Malaria elimination efforts are intensifying globally.
  • Emerging resistance to current antimalarials necessitates novel transmission-blocking strategies.
  • Breaking the Plasmodium falciparum lifecycle is key to preventing malaria spread.

Purpose of the Study:

  • To review the transmission-blocking potential of preclinical antimalarials.
  • To explore non-antimalarial drugs and experimental compounds with transmission-blocking capabilities.
  • To identify novel drug prototypes for next-generation malaria transmission-blocking therapies.

Main Methods:

  • Literature review of preclinical antimalarials.
  • Analysis of non-antimalarial drugs and experimental compounds for transmission-blocking activity.
  • Structure-activity relationship assessment of identified compounds.

Main Results:

  • Identified several preclinical antimalarials with transmission-blocking potential.
  • Highlighted non-antimalarial drugs and experimental compounds exhibiting transmission-blocking effects.
  • Provided insights into structural features contributing to transmission-blocking activity.

Conclusions:

  • Preclinical antimalarials and repurposed drugs offer promising avenues for malaria transmission control.
  • Further investigation into these compounds could lead to innovative next-generation transmission-blocking drugs.
  • Targeting parasite transmission is essential for achieving malaria elimination goals.